BIOAMBER INC - *W EXP 05/09/201 (BIOAWS)

CUSIP: 09072Q114

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / *W EXP 05/09/201
Total 13F shares
5,127,230
Share change
-149,910
Total reported value
$9,134,000
Price per share
$1.81
Number of holders
11
Value change
-$212,875
Number of buys
3
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 09072Q114?
CUSIP 09072Q114 identifies BIOAWS - BIOAMBER INC - *W EXP 05/09/201 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOAMBER INC - *W EXP 05/09/201 (BIOAWS) as of Q1 2016

As of 31 Mar 2016, BIOAMBER INC - *W EXP 05/09/201 (BIOAWS) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,127,230 shares. The largest 10 holders included WADDELL & REED FINANCIAL INC, ARROWGRASS CAPITAL PARTNERS (US) LP, Pine River Capital Management L.P., LEVIN CAPITAL STRATEGIES, L.P., MOORE CAPITAL MANAGEMENT, LP, SOROS FUND MANAGEMENT LLC, Monashee Investment Management LLC, BROWN ADVISORY INC, Park West Asset Management LLC, and ROYAL BANK OF CANADA. This page lists 11 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.